At scPharmaceuticals, we are committed to bringing the advantages of subcutaneous drug administration—an optimized way to deliver infused therapies otherwise only available through intravenous (IV) administration—to more patients and more therapeutic areas through our innovative patent- and market-protected solutions.

By applying our proprietary technology to trusted standard-of-care medications, we aim to reduce the need for inpatient IV infusion. In doing so, we have the potential to transform infused therapies, improve patient care, reduce hospitalizations, and lessen healthcare costs.

At scPharmaceuticals, we are committed to bringing the advantages of subcutaneous drug administration—an optimized way to deliver infused therapies.